dc.contributor.author | Scott, BG | |
dc.contributor.author | Yu, X | |
dc.contributor.author | Ischenko, A | |
dc.contributor.author | Tuzun, E | |
dc.contributor.author | Christadoss, P | |
dc.contributor.author | Yang, H | |
dc.contributor.author | Alagappan, D | |
dc.date.accessioned | 2021-03-05T17:49:20Z | |
dc.date.available | 2021-03-05T17:49:20Z | |
dc.date.issued | 2005 | |
dc.identifier.citation | Yang H., Tuzun E., Alagappan D., Yu X., Scott B., Ischenko A., Christadoss P., "IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1", JOURNAL OF IMMUNOLOGY, cilt.175, ss.2018-2025, 2005 | |
dc.identifier.issn | 0022-1767 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_c7626cab-d1ea-4b4a-bd35-4b8d83341a8d | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/132169 | |
dc.identifier.uri | https://doi.org/10.4049/jimmunol.175.3.2018 | |
dc.description.abstract | In myasthenia gravis (MG), TNF and IL-10 polymorphisms and high serum levels of these proinflammatory cytokines have been observed. Likewise, TNF and IL-1 beta are critical for the activation of acetylcholine receptor (AChR)-specific T and B cells and for the development of experimental autoimmune myasthenia gravis (EAMG) induced by AChR immunization. We tested the therapeutic effect of human recombinant IL-1 receptor antagonist (IL-1ra) in C57BL/6 mice with EAMG. Multiple daily injections of 0.01 mg of IL-Ira administered for 2 wk following two AChR immunizations decreased the incidence and severity of clinical EAMG. Furthermore, IL-1ra treatment of mice with ongoing clinical EAMG reduced the clinical symptoms of disease. The IL-1ra-mediated suppression of clinical disease was associated with suppressed serum IFN-gamma, TNF-alpha, IL-1 beta, IL-2, IL-6, C3, and anti-AChR IgG1 without influencing total serum IgG. Therefore, IL-Ira could be used as a nonsteroidal drug for the treatment of MG. | |
dc.language.iso | eng | |
dc.subject | İmmünoloji | |
dc.subject | Temel Bilimler | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.title | IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1 | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF IMMUNOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 175 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 2018 | |
dc.identifier.endpage | 2025 | |
dc.contributor.firstauthorID | 1973 | |